Simplify Asset Management Inc. cut its stake in agilon health, inc. (NYSE:AGL - Free Report) by 34.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 110,520 shares of the company's stock after selling 58,176 shares during the quarter. Simplify Asset Management Inc.'s holdings in agilon health were worth $210,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently modified their holdings of AGL. Oak Thistle LLC bought a new stake in agilon health during the fourth quarter worth $25,000. Ieq Capital LLC purchased a new stake in shares of agilon health in the fourth quarter valued at about $26,000. Signaturefd LLC lifted its position in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health during the third quarter worth about $28,000. Finally, Raymond James Financial Inc. bought a new stake in agilon health in the 4th quarter worth about $33,000.
agilon health Price Performance
NYSE:AGL traded up $0.08 during trading hours on Thursday, hitting $4.60. The stock had a trading volume of 3,152,704 shares, compared to its average volume of 4,592,088. The company has a 50 day simple moving average of $3.65 and a two-hundred day simple moving average of $2.97. The firm has a market capitalization of $1.89 billion, a price-to-earnings ratio of -4.89 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73.
Analyst Upgrades and Downgrades
AGL has been the topic of several recent analyst reports. Royal Bank of Canada lifted their target price on shares of agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Citigroup upgraded agilon health from a "sell" rating to a "neutral" rating and lifted their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Needham & Company LLC restated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Sanford C. Bernstein lifted their target price on agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a research note on Wednesday, January 15th. Finally, Stifel Nicolaus increased their price target on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research report on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $3.95.
Get Our Latest Analysis on agilon health
agilon health Company Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.